Here are five things to know:
1. Wells Fargo set a “market perform” rating on Mazor stocks.
2. WallachBeth Capital lowered the price target from $21 to $16 recently.
3. Needham & Company downgraded the Mazor stock from a “buy” to a “hold” in February.
4. The stock’s market cap is $248.24 million.
5. The stock has a 50-day moving average of $11.
More articles on orthopedic devices:
Ortho Kinematics raises $9.6M in Series C equity financing
NuVasive shares’ mean target price set at $54
Long Beach Memorial 1st in region to incorporate MAKOplasty procedures
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
